106 related articles for article (PubMed ID: 6484439)
1. [Therapeutic heparinization by subcutaneous route with individualized adjustment of the injected dose and of the time schedule of administration].
Langer B; Montagnini AL; Kutner JM; Khoury V; Albers MT; Puech-Leão LE
Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):35-9. PubMed ID: 6484439
[No Abstract] [Full Text] [Related]
2. [Experiences with Calciparin, a new subcutaneously injectable heparin preparation].
Sessner HH; Brockhaus W; Kunzmann G; Stingl J
Med Welt; 1971 Jan; 5():187-91. PubMed ID: 5546024
[No Abstract] [Full Text] [Related]
3. [Use of calcium heparinate in anticoagulant therapy].
Vivien P; Allannic H; Loussouarn J; Turpin J
Therapie; 1971; 26(1):141-8. PubMed ID: 5554761
[No Abstract] [Full Text] [Related]
4. [Anticoagulant treatment with heparin].
Langer B; Wolosker M; Albers MT
Rev Paul Med; 1982; 99(1):31-2. PubMed ID: 7146741
[No Abstract] [Full Text] [Related]
5. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
Greene CE; Meriwether E
Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
[TBL] [Abstract][Full Text] [Related]
6. [Control of subcutaneous calcium-heparin therapy by the thrombodensitogram].
Porta A; Magni S; Camagna P; Donati M; Dinelli CA
Minerva Med; 1985 Mar; 76(11):531-2. PubMed ID: 3982692
[No Abstract] [Full Text] [Related]
7. [Prevention of thromboembolism using subcutaneous heparin].
Saggau W; Encke A; Schmidt U
Chirurg; 1974 Sep; 45(9):407-9. PubMed ID: 4425325
[No Abstract] [Full Text] [Related]
8. Guidelines for administering heparin.
Thurber CF
J Maine Med Assoc; 1974 Sep; 65(9):212-3. PubMed ID: 4413614
[No Abstract] [Full Text] [Related]
9. [Comparative studies on subcutaneous Heparin administration].
Popov-Cenić S; Borgolte H
Med Welt; 1973 Nov; 24(44):1701-5. PubMed ID: 4764859
[No Abstract] [Full Text] [Related]
10. [Heparin].
Aiach M; Fiessinger JN; Chousterman M
Rev Prat; 1977 Dec; 27(57):3953-74. PubMed ID: 345399
[No Abstract] [Full Text] [Related]
11. [Prolonged anticoagulant treatment by subcutaneous heparin. Experiences in the Resuscitation Center of the Claude Bernard Hospital].
Amstutz P; Szekely AM; Pocidalo JJ
Anesth Analg (Paris); 1968; 25(2):203-12. PubMed ID: 5674781
[No Abstract] [Full Text] [Related]
12. [A new method of heparin therapy: subcutaneous administration in thromboembolism].
Rák K
Orv Hetil; 1989 Feb; 130(6):295-7. PubMed ID: 2922193
[No Abstract] [Full Text] [Related]
13. Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.
Kearon C
Curr Opin Pulm Med; 2007 Sep; 13(5):398-402. PubMed ID: 17940484
[TBL] [Abstract][Full Text] [Related]
14. [An effective heparin treatment by subcutaneous route in general surgery].
Goinard P; Thouverez JP; Belleville JF; Croizat P
Lyon Chir; 1967 Jul; 63(4):600-3. PubMed ID: 5613088
[No Abstract] [Full Text] [Related]
15. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
Prandoni P; Carnovali M; Marchiori A;
Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
[TBL] [Abstract][Full Text] [Related]
16. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
[TBL] [Abstract][Full Text] [Related]
17. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
Hull RD; Pineo GF; Stein P
Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of various methods of heparin treatment].
Chojnowski K; Judkiewicz L; Ciszewski R; Majda J
Pol Tyg Lek; 1985 Nov; 40(44):1232-4. PubMed ID: 3911186
[No Abstract] [Full Text] [Related]
19. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
Monreal M; Lafoz E; Olive A; del Rio L; Vedia C
Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649
[TBL] [Abstract][Full Text] [Related]
20. Rationale and usefulness of heparinization: an overview.
Palmer RL
Tex Med; 1977 May; 73(5):68-72. PubMed ID: 860281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
